Across TCGA pan-cancer cohorts, MORN5 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MORN5 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MORN5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MORN5 expression acts as an unfavorable survival marker.

BRCA, LGG, and LUAD are the cancer types where MORN5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.096	0.578	.002	24	view →
LGG	DFS	Median	All	0.080	0.826	<.001	6	view →
LUAD	OS	Median	All	0.323	0.834	.003	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MORN5 tumor-vs-normal RNA expression · all MORN5 data types